Eugene Myron Holuka
Director, Citius Pharmaceuticals, Inc.
Companies
- CITIUS ONCOLOGY, INC.Board member Aug 16, 2024 to now1
- Citius Pharmaceuticals, Inc.Board member Jun 29, 2016 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CITIUS ONCOLOGY, INC. CTOR300,000 shares3$212.1K at $0.71Sep 19, 2025
- Citius Pharmaceuticals, Inc. CTXR2,367 shares4$1.0K at $0.42Nov 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 19, 2025Granted 300,000 shares of CITIUS ONCOLOGY, INC.5
- Sep 19, 2025Granted 300,000 shares of CITIUS ONCOLOGY, INC.3
- Sep 19, 2025Granted 300,000 shares of CITIUS ONCOLOGY, INC.6
- Mar 13, 2024Shares withheld for tax 48 shares at $0.75 of Citius Pharmaceuticals, Inc.7
- Mar 13, 2024Exercised options 2,415 shares at $0.02 of Citius Pharmaceuticals, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCITIUS ONCOLOGY, INC., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Sep 23, 2025
- 6SEC EDGARForm 4 filed Dec 1, 2025
- 7SEC EDGARForm 4 filed Aug 30, 2024